|
[1]OKAMOTO H, IMAI M, KAMETANI M, et al.Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission[J].Jpn J Exp Med, 1987, 57 (4) :231-236.[2]STERNECK M, GUNTHER S, GERLACH J, et al.Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis[J].J Hepatol, 1997, 26 (4) :754-764.[3]GUNTHER S, FISCHER L, PULT I, et al.Naturally occurring variants of hepatitis B virus[J].Adv Virus Res, 1999, 52:25-137.[4]NORDER H, COUROUCE AM, COURSAGET P, et al.Genetic diversity of hepatitis B virus strains derived worldwide:genotypes, subgenotypes, and HBsAg subtypes[J].Intervirology, 2004, 47 (6) :289-309.[5]TRAN TT, TRINH TN, ABE K.New complex recombinant genotype of hepatitis B virus identified in Vietnam[J].J Virol, 2008, 82 (11) :5657-5663.[6]OLINGER CM, JUTAVIJITTUM P, HUBSCHEN JM, et al.Possible new hepatitis B virus genotype, southeast Asia[J].Emerg Infect Dis, 2008, 14 (11) :1777-1780.[7]GERLICH WH.Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting[J].Intervirology, 2004, 47 (6) :310-313.[8]NORDER H, COUROUCE AM, MAGNIUS LO.Molecular basis of hepatitis B virus serotype variations within the four major subtypes[J].J Gen Virol, 1992, 73 (Pt 12) :3141-3145.[9]KAY A, ZOULIM F.Hepatitis B virus genetic variability and evolution[J].Virus Res, 2007, 127 (2) :164-176.[10]HSU HY, CHANG MH, NI YH, et al.Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan[J].Gut, 2004, 53 (10) :1499-1503.[11]ZOULIM F, LOCARNINI S.Hepatitis B virus resistance to nucleos (t) ide analogues[J].Gastroenterology, 2009, 137 (5) :1593-1608.[12]CUESTAS ML, MATHET VL, RUIZ V, et al.Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies[J].J Clin Microbiol, 2006, 44 (6) :2191-2198.[13]HSU CW, YEH CT.Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy[J].Hepatology, 2011, 54 (1) :101-108.[14]QIU J, QIN B, RAYNER S, et al.Novel evidence suggests hepatitis B virus surface proteins participate in regulation of HBV genome replication[J].Virol Sin, 2011, 26 (2) :131-138.[15]MELLO FC, MARTEL N, GOMES SA, et al.Expression of hepatitis B virus surface antigen containing Y100C variant frequently detected in occult HBV infection[J].Hepat Res Treat, 2011, 2011:695859.[16]SVICHER V, CENTO V, BERNASSOLA M, et al.Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection[J].Antiviral Res, 2012, 93 (1) :86-93.[17]MARTIN CM, WELGE JA, ROUSTER SD, et al.Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro[J].J Viral Hepat, 2012, 19 (10) :716-723.[18]ITO K, QIN Y, GUARNIERI M, et al.Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site[J].J Virol, 2010, 84 (24) :12850-12861.[19]TIAN Y, XU Y, ZHANG Z, et al.The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen[J].J Clin Microbiol, 2007, 45 (9) :2971-2978.[20]EL CHAAR M, CANDOTTI D, CROWTHER RA, et al.Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection[J].Hepatology, 2010, 52 (5) :1600-1610.[21]WU C, DENG W, DENG L, et al.Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance[J].J Virol, 2012, 86 (8) :4658-4669.[22]DENG WY.Biochemical and immunological study on amino acid variation at specific site on HBsAg[D].Wuhan Institute of Virology, Chinese Academy of Sciences, 2011. (in Chinese) 邓万玉.乙肝表面抗原特定位点氨基酸变异的生化及免疫学研究[D].中国科学院武汉病毒研究所, 2011.[23]SEDDIGH-TONEKABONI S, WATERS JA, JEFFERS S, et al.Effect of variation in the common“a”determinant on the antigenicity of hepatitis B surface antigen[J].J Med Virol, 2000, 60 (2) :113-121.[24]KALININA T, IWANSKI A, WILL H, et al.Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R[J].Hepatology, 2003, 38 (5) :1274-1281.[25]WU C, ZHANG X, TIAN Y, et al.Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication[J].J Gen Virol, 2010, 91 (Pt 2) :483-492.[26]JEANTET D, CHEMIN I, MANDRAND B, et al.Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays[J].J Med Virol, 2004, 73 (4) :508-515.[27]VERHEYEN J, NEUMANN-FRAUNE M, BERG T, et al.The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays[J].J Clin Virol, 2012, 54 (3) :279-281.[28]SERVANT-DELMAS A, MERCIER-DARTY M, LY TD, et al.Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples[J].J Clin Virol, 2012, 53 (4) :338-345.[29]HSU CW, YEH CT, CHANG ML, et al.Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance[J].Gastroenterology, 2007, 132 (2) :543-550.[30]LA'ULU SL, ROBERTS WL.The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays[J].Am J Clin Pathol, 2006, 125 (5) :748-751.[31]TABOR E.Infections by hepatitis B surface antigen gene mutants in Europe and North America[J].J Med Virol, 2006, 78 (Suppl 1) :s43-s47.[32]OGATA N, ZANETTI AR, YU M, et al.Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant[J].J Infect Dis, 1997, 175 (3) :511-523.[33]DAI Y, ZHANG ZH, CHEN L, et al.Molecular epidemiological study of occult hepatitis B virus infection in blood donors[J].Chin J Infect Dis, 2012, 30 (4) :235-239. (in Chinese) 戴钰, 张振华, 陈玲, 等.献血员隐匿性乙型肝炎病毒感染的分子流行病学研究[J].中华传染病杂志, 2012, 30 (4) :235-239.[34]ZHANG ZH, LI L, ZHAO XP, et al.Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance[J].J Viral Hepat, 2011, 18 (6) :424-433.[35]LU M, LORENTZ T.De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody[J].J Infect Dis, 2003, 187 (8) :1323-1326.[36]HSU HY, CHANG MH, NI YH, et al.No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization[J].J Infect Dis, 2010, 201 (8) :1192-1200.[37]LAI MW, LIN TY, TSAO KC, et al.Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination[J].Gastroenterology, 2012, 143 (2) :400-407.[38]OON CJ, LIM GK, YE Z, et al.Molecular epidemiology of hepatitis B virus vaccine variants in Singapore[J].Vaccine, 1995, 13 (8) :699-702.[39]LEE PI, CHANG LY, LEE CY, et al.Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth[J].J Infect Dis, 1997, 176 (2) :427-430.[40]NGUI SL, O'CONNELL S, EGLIN RP, et al.Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales[J].J Infect Dis, 1997, 176 (5) :1360-1365.[41]CHEN WN, OON CJ.Human hepatitis B virus mutants:significance of molecular changes[J].FEBS Lett, 1999, 453 (3) :237-242.[42]CHEN CH, CHANGCHIEN CS, LEE CM, et al.Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma:a casecontrol study[J].J Infect Dis, 2008, 198 (11) :1634-1642.
|
PDF下载 ( 1173 KB)
本文二维码
下载:
